Clinical Trials on Type B Aortic Dissection in South Africa
Total 337 results
-
Medtronic CardiovascularNAMSAActive, not recruitingThoracic Aortic DissectionUnited States, Korea, Republic of, Netherlands, Denmark, New Zealand, Thailand, Japan, Slovakia, Greece, Italy
-
Bolton MedicalActive, not recruitingAortic Dissection Type BUnited States
-
Artivion Inc.Syneos HealthRecruitingAcute Aortic DissectionUnited States
-
SCAD AlliancePERFUSE Study GroupRecruitingSpontaneous Coronary Artery DissectionUnited States, Australia
-
Endospan Ltd.RecruitingAortic Aneurysm | Aortic Dissection | Penetrating Aortic Ulcer | Intramural HematomaUnited States, New Zealand
-
GlaxoSmithKlineCompletedDiphtheria; Haemophilus Influenzae Type b; Hepatitis B; Tetanus; Whole Cell PertussisSouth Africa
-
Sanofi Pasteur, a Sanofi CompanyCompletedHepatitis B | Pertussis | Diphtheria | Polio | Haemophilus Influenzae Type bSouth Africa
-
Senesco Technologies, Inc.UnknownMultiple Myeloma | Plasma Cell Leukemia | Multiple Myeloma in Relapse | Mantle Cell Lymphoma in Relapse | Diffuse Large B Cell Lymphoma in Relapse | Other B Cell Lymphoma in RelapseUnited States, South Africa
-
Medical University of South CarolinaCelgene CorporationCompletedLarge B-Cell Diffuse LymphomaUnited States
-
Peter MacCallum Cancer Centre, AustraliaHoffmann-La RocheActive, not recruitingDiffuse Large B Cell Lymphoma | High-grade B-cell LymphomaAustralia
-
Yazeed SawalhaRecruitingZanubrutinib in Combination With R-CHOP (ZaR-CHOP) for Newly Diagnosed Diffuse Large B-Cell LymphomaDiffuse Large B-Cell Lymphoma | Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma | Transformed Marginal Zone Lymphoma to Diffuse Large B-Cell LymphomaUnited States
-
Medical University of South CarolinaRecruitingChronic Lymphocytic Leukemia | B-cell Non Hodgkin LymphomaUnited States
-
Hoffmann-La RocheCompletedDiffuse Large B-Cell Lymphoma, Lymphoma FollicularUnited States, Australia, Italy
-
AmgenMerck Sharp & Dohme LLCCompletedRelapsed or Refractory Diffuse Large B Cell Lymphoma (DLBCL)United States, Germany, Spain, Australia, Netherlands, France
-
Hoosier Cancer Research NetworkEli Lilly and Company; Walther Cancer InstituteTerminatedLymphoma, B-CellUnited States
-
ADC Therapeutics S.A.RecruitingB-Cell Non-Hodgkin Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Relapsed B-Cell Non-Hodgkin LymphomaUnited States, Spain, Italy, United Kingdom, Belgium, Czechia
-
Trans Tasman Radiation Oncology GroupPeter MacCallum Cancer Centre, Australia; Australasian Leukaemia and Lymphoma...UnknownNon-gastric Marginal Zone LymphomaAustralia
-
Medical University of South CarolinaGlaxoSmithKline; Celgene CorporationCompletedChronic Lymphocytic LeukemiaUnited States
-
GlaxoSmithKlineCompletedNeisseria Meningitidis | Haemophilus Influenzae Type bAustralia
-
Antengene Biologics LimitedRecruitingAdvanced Solid Tumor | Metastatic Solid Tumor | Mature B-cell Non-Hodgkin LymphomaUnited States, Australia
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Diffuse Large B-Cell Lymphoma Activated B-Cell Type | Refractory Diffuse Large B-Cell Lymphoma Activated B-Cell TypeUnited States, Saudi Arabia
-
Carilion ClinicSanofiTerminatedAdvanced Endometrial Adenocarcinoma, Stage III A, B, CUnited States
-
Pharmacyclics LLC.Celgene CorporationCompletedDiffuse Large B Cell Lymphoma Refractory | Diffuse Large B Cell Lymphoma RelapsedUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedLymphomaUnited States
-
GlaxoSmithKlineCompletedHib-MenCY-TT Vaccine Study Compared to Licensed Hib and Meningococcal Serogroup C Conjugate VaccinesNeisseria Meningitidis | Haemophilus Influenzae Type bAustralia
-
Kite, A Gilead CompanyRecruitingRelapsed/Refractory Large B-cell LymphomaUnited States, Australia, Canada
-
mAbxience Research S.L.Laboratorio Elea Phoenix S.A.; Libbs Farmacêutica LTDA; Innogene Kalbiotech Pte... and other collaboratorsCompletedDiffuse Large B-cell LymphomaMalaysia, Argentina, Colombia, India, South Africa, Philippines, Brazil, Russian Federation, Indonesia, Iran, Islamic Republic of, Mexico, Paraguay
-
Altor BioScienceTerminatedRelapsed/Refractory Indolent B Cell Non-Hodgkin LymphomaUnited States
-
BeiGeneRecruitingFollicular Lymphoma | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Chronic Lymphocytic Leukemia | Advanced Solid Tumor | Diffuse Large B Cell Lymphoma | Small Lymphocytic LymphomaAustralia, China
-
ADC Therapeutics S.A.CompletedDiffuse Large B-cell LymphomaSpain, United States, Italy, Puerto Rico
-
National Cancer Institute (NCI)CompletedRefractory B-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | CD20 PositiveUnited States
-
Merck Sharp & Dohme LLCActive, not recruitingHodgkin's Lymphoma | Primary Mediastinal Large B-cell Lymphoma (PMBCL)Canada, United States, Brazil, Czechia, France, Italy, Poland, Russian Federation, South Africa, Turkey, Ukraine
-
MedImmune LLCCompletedDiffuse Large B-Cell LymphomaUnited States, France, United Kingdom, Ireland
-
Seagen Inc.Genentech, Inc.CompletedLymphoma, Large B-Cell, Diffuse | Lymphoma, Non-HodgkinUnited States
-
Alliance Foundation Trials, LLC.PfizerActive, not recruitingB Cell Lymphoma | Mantle Cell LymphomaUnited States
-
Afexa Life Sciences IncWithdrawnLeukemia, Lymphocytic, Chronic, B-CellUnited States
-
Hoffmann-La RocheCompletedNon-Hodgkin's LymphomaUnited States, Australia, Italy
-
ImmunoVaccine Technologies, Inc. (IMV Inc.)Merck Sharp & Dohme LLCRecruitingRelapsed Diffuse Large B-cell Lymphoma | Refractory Diffuse Large B-cell LymphomaAustralia, Spain, United States, France, Hungary, New Zealand, Poland, Serbia, Canada, Romania
-
SCRI Development Innovations, LLCGenentech, Inc.; Celgene CorporationCompletedChronic Lymphocytic LeukemiaUnited States
-
AbbVieGenentech, Inc.; AmgenTerminatedAcute Myeloid Leukemia | Non-Hodgkin's Lymphoma | Diffuse Large B-cell LymphomaUnited States, Australia, Germany
-
Karyopharm Therapeutics IncSuspendedRelapsed or Refractory Diffuse Large B-Cell LymphomaUnited States
-
MedImmune LLCCompletedChronic Lymphocytic Leukemia | Non-Hodgkin LymphomaUnited States, Poland
-
Allogene TherapeuticsRecruitingRelapsed/Refractory Large B Cell LymphomaBelgium, United States, Austria
-
SpirogenTerminatedAcute Myeloid Leukemia | Chronic Lymphocytic LeukemiaUnited States
-
Bristol-Myers SquibbCompletedLymphoma. Non-HodgkinGermany, Italy, United States, Spain, Netherlands, Australia, United Kingdom, Belgium, France, Canada, Sweden, Singapore
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)Completed
-
Karyopharm Therapeutics IncRecruitingDiffuse Large B-cell LymphomaUnited Kingdom, United States, Australia, Austria, Belgium, Bulgaria, Canada, France, Germany, Greece, Hungary, India, Israel, Italy, Netherlands, New Zealand, Poland, Serbia, Spain
-
GlaxoSmithKlineCompletedLeukaemia, Lymphocytic, ChronicAustralia, United States, New Zealand
-
BiogenTerminatedChronic Lymphocytic LeukemiaUnited States